1-MNA

Supplement

1-MNA, a novel myokine, is a game-changer in cellular, vascular, and lipid health by blocking the enzyme NNMT and optimizing NAD levels in the cells.

Services
  • Safely Supports NAD Levels
  • Reduces Inflammatory Proteins
  • Supports Healthy Blood Vessels
Location Boulder, Colorado
About

1-MNA

1-MNA or ‘1-methylnicotinamide’ is a unique supplement that helps block the enzyme NNMT, supporting metabolic, brain, and cellular health by optimizing NAD levels.

1-MNA has been shown to inhibit the enzyme NNMT, which when present in high levels, is associated with various diseases. By inhibiting this enzyme, 1-MNA can contribute to overall cellular health and disease prevention.

Researched extensively for its safety profile, 1-MNA supplementation aims to safely restore NAD levels, optimize cellular redox pathways, and combat age-related diseases comprehensively. As a natural byproduct of vitamin B3, 1-MNA also shows anti-inflammatory effects and supports vascular and cardiovascular health, making it a strong candidate for daily use.

* Safely increase NAD levels and block NNMT
* Renowned for its anti-inflammatory and anti-thrombotic qualities
* Improve cell energy metabolism
* Positive effect on Vascular Endothelium
* Lowers levels of inflammatory markers

1-MNA is the flagship supplement of Longevity Launch Labs—affectionately known as Launch. Launch is a dynamic incubator dedicated to fostering groundbreaking products, services, and technologies that address the most pressing challenges in Cellular and Longevity Medicine.

At Launch, we bring years of industry expertise and a deep understanding of the business of medicine to empower founders as they navigate the complexities of today’s healthcare landscape. Our mission is to push the boundaries of innovation and transform the future of healthcare.

Join us in shaping a healthier, longer tomorrow—together.

Unlock exclusive discounts and offers from 1-MNA and other trusted partners with an SSRP Pro Membership.
What People Say

Testimonials

I strongly recommend 1-MNA because it delivers the energy, vascular, and lipid benefits patients are looking for—without the uncertainties that come with NAD precursors. In my clinic, we’ve seen patients experience noticeable improvements in energy and significant gains in lipid profiles, including reductions in Lp(a). Unlike other NAD supplements, which may carry long-term risks, 1-MNA offers a safer, more targeted way to support healthy aging and cellular resilience.

Elizabeth Yurth, MD, ABPMR, ABAARM, FAARM, FAARFM, FSSRP - Co-Founder & Chief Medical Officer - Boulder Longevity Institute Boulder Longevity Institute

Unlike other NAD boosting supplements, 1-MNA is a safe and effective way to restore NAD levels and combat age related diseases, while in addition, improving vascular health, reducing inflammation, having anti-oxidant and neuroprotective properties and improving athletic recovery. I think of it as a kind of “supplement superhero” with a litany of longevity-supporting effects.

Dr. Frank Lipman Founder - Eleven Eleven Wellness Center
Network with our partners

Upcoming Events

View Upcoming Events
EVENT
Grand Rounds
December 4 - 5, 2026

Grand Rounds

Coming Soon
RESOURCES

Join us in breaking down the latest research live.

VIEW ALL
Peptide Therapy Foundations: Full Curriculum
A fundamental understanding of the most clinically relevant peptides today. Foundations takes you through each covered peptide in depth: how it works, what the latest research shows, and how it’s applied in practice, all taught with one consistent clinical lens....
60 Lessons
View Course
PODCAST
Redox Revolution
Nov 17, 2026
Ep.86 – Understanding SNPs: The Tiny, One-Letter Variations in Your DNA
Ep.86 – Understanding SNPs: The Tiny, One-Letter Variations in Your DNA

In this episode of Redox Revolution, Dr. Seeds discusses genomics, SNPs, and how to make sense of Genetic Testing.

Cellular Medicine Foundations
VIDEO
Cellular Medicine Mondays
Nov 16, 2026
Ep. 114 Anti-Aging Mini Mastermind Part 4
Preview only
Journal Club – Episode 114

In Part 4 of the Anti-Aging Mini Mastermind, Dr. Seeds explores how NAD synthesis, mitochondrial function, and cellular signaling influence immune function, inflammation, and aging through the lens of cellular medicine.

Preview Only — Become a member for full access
SSRP Institute Nov 12, 2026
FDA Requires New Safety Warnings for GLP-1 Receptor Agonists Due to Potential Vision Risk
BREAKING NEWS [NOVEMBER 12, 2026] – On November 9, the U.S. Food and Drug Administration (FDA) announced new safety labeling requirements for glucagon-like peptide-1 receptor agonists (GLP-1 RAs), citing a potential increased risk of nonarteritic anterior ischemic optic neuropathy (NAION), a rare but serious condition that can cause sudden, painless vision loss, sometimes permanently. The […]
READ NEWS
Promoitalia Nov 5, 2026
SSRP Institute Welcomes Promoitalia as New Trusted Partner
PARTNER ANNOUNCEMENT WILLOUGHBY, Ohio, [November 5, 2026] — The SSRP Institute announces that Promoitalia has joined its Trusted Partner Network following nomination and completion of the SSRP’s internal review process. Promoitalia is an Italian aesthetic medicine company that develops professional technologies, methodologies, and consumable products for regenerative aesthetics and skin health. Its work combines professional […]
READ NEWS
SSRP Institute Oct 29, 2026
Dr. Seeds and Medivive Announce the Redox Smart Pen: A Novel Technology for Precise Peptide Administration
BREAKING NEWS WILLOUGHBY, Ohio [October 29, 2026] — Dr. Seeds and Medivive announce the launch of the Redox Smart Pen, an innovative pre-filled autoinjector peptide delivery system designed to improve precision and consistency in physician-directed peptide protocols. Importantly, the Redox Smart Pen was developed through a proprietary methodology focused on uniform potency, accuracy of administration, […]
READ NEWS
PharmaNutra Oct 22, 2026
SSRP Institute Welcomes PharmaNutra as New Trusted Partner
PARTNER ANNOUNCEMENT WILLOUGHBY, Ohio, [October 22, 2026] — The SSRP Institute announces that PharmaNutra has joined its Trusted Partner Network following nomination and completion of the SSRP’s internal review process. Founded in Italy in 2003, PharmaNutra is a pharmaceutical and nutraceutical company focused on the research, development, and production of nutritional supplements and medical devices. […]
READ NEWS
ARTICLE
William Seeds, MD
Oct 8, 2026
EP2, Tissue-Resident Macrophages, and a New Mechanism of Organ Aging
William Seeds, MD Oct 8, 2026
EP2, Tissue-Resident Macrophages, and a New Mechanism of Organ Aging
Revisiting a Journal Club Article, “Restored clearance of senescent neutrophils by tissue-resident macrophages limits organ aging.” Science. 2026  Why This Paper Matters Most of the senescence conversation over the past decade has centered on a familiar cast: senescent fibroblasts, endothelial cells, adipocytes, and the drugs designed to clear them. This paper, which I discuss in […]
READ ARTICLE
Healthgevity Oct 2, 2026
Healthgevity Introduces hydraCELL+™, Featuring Formulation IP Developed by the Seeds Foundation for Cellular Research
BREAKING NEWS INTERLAKEN, N.J., [October 2, 2026] — Healthgevity, a practitioner-focused precision longevity nutrition company, announced the launch of hydraCELL+™, a cellular hydration and muscle-support formula built on proprietary formulation IP developed through the Seeds Foundation for Cellular Research and licensed to Healthgevity. The formula reflects the cellular medicine approach advanced by William Seeds, MD, and […]
READ NEWS
ARTICLE
William Seeds, MD
Sep 23, 2026
The Future of Regenerative Medicine May Begin with a Hair Follicle
William Seeds, MD Sep 23, 2026
The Future of Regenerative Medicine May Begin with a Hair Follicle
Why a Plucked Hair Follicle May Matter to the Future of Regenerative Medicine In this article, I return to a study that I discussed in a July Journal Club post. The study, published in Cells in 2024, investigated whether cells obtained from plucked, cryopreserved human hair follicles could be reprogrammed into induced pluripotent stem cells […]
READ ARTICLE